M T Alkire1. 1. University of California-Irvine Medical Center, Department of Anesthesiology, Orange 92668, USA. MAlkire@uci.edu
Abstract
BACKGROUND: To help elucidate the relationship between anesthetic-induced changes in the electroencephalogram (EEG) and the concurrent cerebral metabolic changes caused by anesthesia, positron emission tomography data of cerebral metabolism obtained in volunteers during anesthesia were correlated retrospectively with various concurrently measured EEG descriptors. METHODS: Volunteers underwent functional brain imaging using the 18fluorodeoxyglucose technique; one scan always assessed awake-baseline cerebral metabolism (n = 7), and the other scans assessed metabolism during propofol sedation (n = 4), propofol anesthesia (n = 4), or isoflurane anesthesia (n = 5). The EEG was recorded continuously during metabolism assessment using a frontal-mastoid montage. Power spectrum variables, median frequency, 95% spectral edge, and bispectral index (BIS) values subsequently were correlated with the percentage of absolute cerebral metabolic reduction (PACMR) of glucose utilization caused by anesthesia. RESULTS: The percentage of absolute cerebral metabolic reduction, evident during anesthesia, trended median frequency (r = -0.46, P = 0.11), and the spectral edge (r = -0.52, P = 0.07), and correlated with anesthetic type (r = -0.70, P < 0.05), relative beta power (r = -0.60, P < 0.05), total power (r = 0.71,P < 0.01), and bispectral index (r = -0.81,P < 0.001). After controlling for anesthetic type, only bispectral index (r = 0.40, P = 0.08) and alpha power (r = 0.37, P = 0.10) approached significance for explaining residual percentage of absolute cerebral metabolic reduction prediction error. CONCLUSIONS: Some EEG descriptors correlated linearly with the magnitude of the cerebral metabolic reduction caused by propofol and isoflurane anesthesia. These data suggest that a physiologic link exists between the EEG and cerebral metabolism during anesthesia that is mathematically quantifiable.
BACKGROUND: To help elucidate the relationship between anesthetic-induced changes in the electroencephalogram (EEG) and the concurrent cerebral metabolic changes caused by anesthesia, positron emission tomography data of cerebral metabolism obtained in volunteers during anesthesia were correlated retrospectively with various concurrently measured EEG descriptors. METHODS: Volunteers underwent functional brain imaging using the 18fluorodeoxyglucose technique; one scan always assessed awake-baseline cerebral metabolism (n = 7), and the other scans assessed metabolism during propofol sedation (n = 4), propofol anesthesia (n = 4), or isoflurane anesthesia (n = 5). The EEG was recorded continuously during metabolism assessment using a frontal-mastoid montage. Power spectrum variables, median frequency, 95% spectral edge, and bispectral index (BIS) values subsequently were correlated with the percentage of absolute cerebral metabolic reduction (PACMR) of glucose utilization caused by anesthesia. RESULTS: The percentage of absolute cerebral metabolic reduction, evident during anesthesia, trended median frequency (r = -0.46, P = 0.11), and the spectral edge (r = -0.52, P = 0.07), and correlated with anesthetic type (r = -0.70, P < 0.05), relative beta power (r = -0.60, P < 0.05), total power (r = 0.71,P < 0.01), and bispectral index (r = -0.81,P < 0.001). After controlling for anesthetic type, only bispectral index (r = 0.40, P = 0.08) and alpha power (r = 0.37, P = 0.10) approached significance for explaining residual percentage of absolute cerebral metabolic reduction prediction error. CONCLUSIONS: Some EEG descriptors correlated linearly with the magnitude of the cerebral metabolic reduction caused by propofol and isoflurane anesthesia. These data suggest that a physiologic link exists between the EEG and cerebral metabolism during anesthesia that is mathematically quantifiable.
Authors: Justus Schneider; Nikolaus Berndt; Ismini E Papageorgiou; Jana Maurer; Sascha Bulik; Martin Both; Andreas Draguhn; Hermann-Georg Holzhütter; Oliver Kann Journal: J Cereb Blood Flow Metab Date: 2017-11-03 Impact factor: 6.200
Authors: Fahmeed Hyder; Robert K Fulbright; Robert G Shulman; Douglas L Rothman Journal: J Cereb Blood Flow Metab Date: 2013-01-09 Impact factor: 6.200
Authors: Bojan Musizza; Aneta Stefanovska; Peter V E McClintock; Milan Palus; Janko Petrovcic; Samo Ribaric; Fajko F Bajrovic Journal: J Physiol Date: 2007-01-18 Impact factor: 5.182
Authors: Teresa L May; David B Seder; Gilles L Fraser; Philip Stone; Barbara McCrum; Richard R Riker Journal: Neurocrit Care Date: 2015-02 Impact factor: 3.210
Authors: Patrick L Purdon; Eric T Pierce; Giorgio Bonmassar; John Walsh; P Grace Harrell; Jean Kwo; Daniel Deschler; Margaret Barlow; Rebecca C Merhar; Camilo Lamus; Catherine M Mullaly; Mary Sullivan; Sharon Maginnis; Debra Skoniecki; Helen-Anne Higgins; Emery N Brown Journal: Ann N Y Acad Sci Date: 2009-03 Impact factor: 5.691
Authors: Natasja J G Maandag; Daniel Coman; Basavaraju G Sanganahalli; Peter Herman; Arien J Smith; Hal Blumenfeld; Robert G Shulman; Fahmeed Hyder Journal: Proc Natl Acad Sci U S A Date: 2007-12-13 Impact factor: 11.205